Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 1 month ago
Duration: 0h 4m 27s
Indian pharma companies see sharp drop in adverse USFDA findings in 2025
The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025.
Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.
Uploaded by: Rediff Video Desk on Thu, 08 Jan 2026 11:21:23 +0530
Views: 36
Tags: Indian pharma companies see sharp drop in adverse USFDA findings in 2025
© 2026